CClinicalTrials.gg
CompletedNCT06656455Updated May 22, 2025

Sevoflurane and Laryngeal Mask Airway Versus Propofol Infusion and Facemask for EUA in Children

An interventional study of sevoflurane via LMA and Propofol with oxygen via simple mask in Anesthesia and Children, Only, sponsored by American University of Beirut Medical Center. Completed at 1 site in Lebanon. Open to participants aged 1 Year to 6 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-05-22.

Sponsored by American University of Beirut Medical Center · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 7 years 4 months after the study started (first participant enrolled May 2017, registered Oct 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
1 Year to 6 Years
Sex
All
01

Study summary

The goal of this clinical trial is to find out the optimal technique of anesthesia for eye examination in children. The main question it aims to answer is:

Is propofol infusion and simple oxygen facemask associated with earlier discharge from the operating room, and hence rapid turnover and greater efficiency compared to sevoflurane via LMA? Researchers will compare time to discharge from the operating room to see if eye examination for children less than 7 years using a propofol infusion pump based anesthesia and simple oxygen facemask results in a shorter discharge time from the operating room in comparison with sevoflurane via LMA.

Participants will will be assigned to receive general anesthesia by one of two treatment groups.

Read the detailed description

Children younger than 5 years can be uncooperative during an examination and may render it impossible. The main objective of anesthesia for ophthalmic examination is to provide ideal conditions for optimal exam with a quick onset and offset of anesthesia as well as rapid recovery and early discharge. Two commonly used sedation techniques for young children are: sevoflurane via laryngeal mask airway (LMA) or propofol infused intravenously. Both have been shown to be safe and effective and allow rapid changes in anesthesia depth and minimal postoperative morbidity. However, their induction, emergence characteristics, and side effect profiles may differ. From previous studies, it is still not evident whether propofol infusion using oxygen facemask or sevoflurane administration via LMA is superior with respect to earlier discharge from operating room in children undergoing eye examination under anesthesia (EUA).

In the literature, there are no studies directly comparing those two different techniques for ophthalmic examination.

The aim of this study is to find out the optimal technique of anesthesia for eye examination in children resulting in earlier discharge from the operating room thus decreasing the turnover time between cases and providing optimal surgical conditions, without interfering with the well-being of the child or compromising the airway security.

In a prospective randomized study, a total sample of 60 children scheduled for eye examination under anesthesia (30 in each arm of the study) aged between 1-7 years with American Society of Anesthesiologists physical status 1 to 3 will be assigned to receive general anesthesia by one of two treatment groups. After induction with sevoflurane 8% in oxygen, patients randomized to group S will be given propofol 2 mg/kg and fentanyl 1µg/kg intravenously and anesthesia will be maintained with sevoflurane via LMA. Patients randomized to group P will be given propofol 1 mg/kg and fentanyl 1µg/kg intravenously and anesthesia will be maintained with a continuous infusion of propofol 200 µg/kg/min with oxygen 3 L/min via simple mask and oral airway if needed. In both groups sevoflurane concentration or propofol infusion will be titrated to keep optimal conditions. The primary outcome is time to discharge from the operating room. Secondary outcomes are surgical conditions, respiratory events, agitation and other side effects as well as recovery times. Normally distributed data will be summarized as mean ± SD and nonnormally distributed data will be summarized as median [interquartile range].

It is believed that propofol infusion and simple oxygen facemask will be associated with earlier discharge from the operating room, and hence rapid turnover and greater efficiency compared to sevoflurane via LMA. This study would have an impact on the current practice for pediatric ophthalmic EUA and may help find out the best technique that decreases the turnover time between cases resulting in higher operating time efficiency while providing optimal surgical conditions and patients' safety.

02

Conditions studied

  • Anesthesia
  • Children, Only
03

In context

Lead sponsor

American University of Beirut Medical Center is the lead sponsor of 152 studies on the registry; 27 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Year to 6 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Children presented to the Operating Room of the American University of Beirut Medical Center
  • 1 to 6 years old
  • With American Society of Anesthesiologists physical status 1-3
  • Scheduled for ophthalmic EUA with or without laser/cryotherapy procedure

Exclusion criteria

Exclusion Criteria:

  • Children with full stomach or significant aspiration risk (including hiatal hernia)
  • Children who are morbidly obese or have a current upper respiratory tract infection
  • Children who have oropharyngeal pathology (e.g., radiotherapy for hypopharynx/larynx), tracheostomies, or a family history of malignant hyperthermia
  • Children of parents who refuse to give consent
  • Children having allergy to the anesthetics used
  • Any surgical procedure expected to last for more than 60 minutes
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
60 participants (actual)

Study arms

  • Active comparator
    Group S

    Group S will be given propofol 2 mg/kg and fentanyl 1µg/kg intravenously and anesthesia will be maintained with sevoflurane via LMA

    Drug: sevoflurane via LMA

  • Experimental
    Group P

    Patients randomized to group P will be given propofol 1 mg/kg and fentanyl 1µg/kg intravenously and anesthesia will be maintained with a continuous infusion of propofol 200 µg/kg/min with oxygen 3 L/min via simple mask and oral airway if needed.

    Drug: Propofol with oxygen via simple mask

Interventions

  • Drugsevoflurane via LMA

    In Group S, co-induction is used whereby the patient continues to receive 8% sevoflurane through the facemask followed after IV insertion by propofol 2mg/kg and fentanyl 1mic/kg administration. Thirty seconds afterwards, an age-appropriate LMA will be inserted. Sevoflurane is maintained initially at a concentration of 2%. The ventilation at first is assisted manually until the child starts breathing. If movement requires interruption of the exam, a bolus of propofol 1mg/kg is given and sevoflurane is increased by 1% until a maximal sevoflurane concentration of 4%. If apnea related to the depth of anesthesia occurs more than 10 sec or the saturation drops below 94%, sevoflurane will be turned off until the proper airway intervention is taken to achieve saturation above 95% and sevoflurane will be resumed at a concentration decreased by 1%.

  • DrugPropofol with oxygen via simple mask

    In group P, the sevoflurane will be discontinued, and propofol 1 mg/kg and fentanyl 1µg/kg will be administered IV. Propofol pump is maintained initially at a rate of 200mic/kg/min. with oxygen at 3 liters/min via facemask. If movement requires interruption of the exam, a bolus of propofol 1mglkg is given and the infusion rate is increased by 20mic/kg/min up to a maximal rate of 350mic/kg/min. The total number of boluses needed will be recorded as the need for additional sedation. If apnea related to the depth of anesthesia occurs more than 10 sec or the saturation drops below 94%, the infusion pump will be stopped until the proper airway intervention is taken to achieve saturation above 95% with spontaneous breathing. Afterwards, the propofol pump will be resumed at a rate decreased by 20mic/kg/min.

06

What researchers measure

Primary outcomes

  1. Time to discharge from the operating room

    Time to discharge from the operating room in minutes

    Time frame: Time from the end of surgery to discharge from OR, assessed up to 40 minutes

Secondary outcomes

  1. Duration of anesthesia

    Duration of anesthesia in minutes

    Time frame: From the start till the end of anesthesia, assessed up to 120 minutes

  2. Duration of surgical procedure

    Duration of surgical procedure in minutes

    Time frame: From the start of eye examination till the completion of the procedure, assessed up to 60 minutes

  3. Ophthalmologist satisfaction score

    Ophthalmologist satisfaction score measured on likert scale (ranging from 1 till 5 with 1 representing the least degree of satisfaction and 5 the highest).

    Time frame: During the procedure

  4. Apnea

    Apnea \>10 seconds

    Time frame: During the procedure

  5. Desaturation

    SPO2\<94%

    Time frame: During the procedure

  6. Laryngospasm

    Laryngospasm requiring treatment

    Time frame: During the procedure

  7. Interruption

    Number of interruptions of EUA

    Time frame: During the procedure

  8. Emergence agitation

    Emergence agitation on a four-point scale

    Time frame: Immediately after the procedure

  9. Wake up time

    Wake up time in minutes

    Time frame: Time from the end of anesthesia drug administration to spontaneous eye opening, assessed up to 180 minutes

  10. PACU stay duration

    PACU stay duration in minutes

    Time frame: Time from arrival to PACU till achievement of an Aldrete score of 9, assessed up to 180 minutes

  11. Change in the airway management

    Change in the airway management

    Time frame: Number of participants with change in airway management assessed by the data collector during the procedure

  12. Emesis

    Emesis

    Time frame: Number of participants who developed emesis, assessed by the data collector immediately after the procedure

  13. Administration of pain medication

    Administration of pain medication

    Time frame: Number of participants who were administered pain medication, assessed by the data collector immediately after the procedure

  14. Airway Obstruction

    Airway Obstruction

    Time frame: Number of participants who had an airway obstruction, assessed by the data collector during the procedure

  15. Hypoventilation

    Hypoventilation

    Time frame: Number of participants who developed hypoventilation, assessed by the data collector during the procedure

  16. Excess secretions

    Excess secretions

    Time frame: Number of participants who developed excess secretions, assessed by the data collector during the procedure

  17. Induction time

    Induction time in minutes

    Time frame: Time from anesthesia start to surgery start, assessed up to 60 minutes

  18. Nonoperative time

    Nonoperative time in minutes

    Time frame: Time from anesthesia start to surgery start combined with the time to discharge from OR, assessed up to 60 minutes

07

Study locations

1 site
  • American University of Beirut Medical Center
    Beirut, Lebanon
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 22, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06656455
Lead sponsor
American University of Beirut Medical Center
Responsible party
Cynthia Karam (Principal Investigator, American University of Beirut Medical Center) — Principal investigator
First posted
Oct 24, 2024
Start date
May 23, 2017
Primary completion
Jul 8, 2024
Completion
Jul 8, 2024
Last update
May 22, 2025

Study contacts

Cynthia Karam, MD
principal investigator · American University of Beirut Medical Center

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion